These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31236781)

  • 21. Liquisolid compacts: the effect of cosolvent and HPMC on theophylline release.
    Nokhodchi A; Aliakbar R; Desai S; Javadzadeh Y
    Colloids Surf B Biointerfaces; 2010 Aug; 79(1):262-9. PubMed ID: 20451361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation of sustained-release dosage form of Venlafaxine HCl using liquisolid technique.
    Khanfar M; Sheikh Salem M; Kaddour F
    Pharm Dev Technol; 2014 Feb; 19(1):103-15. PubMed ID: 23347382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of ketoconazole dissolution rate by the liquisolid technique.
    Molaei MA; Osouli-Bostanabad K; Adibkia K; Shokri J; Asnaashari S; Javadzadeh Y
    Acta Pharm; 2018 Sep; 68(3):325-336. PubMed ID: 31259692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liquisolid systems and aspects influencing their research and development.
    Vraníková B; Gajdziok J
    Acta Pharm; 2013 Dec; 63(4):447-65. PubMed ID: 24451071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Technical Approach of Solubility Enhancement of Poorly Soluble Drugs: Liquisolid Technique.
    Chaudhary N; Tripathi D; Rai AK
    Curr Drug Deliv; 2020; 17(8):638-650. PubMed ID: 32416691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Liquisolid technique for enhancement of dissolution prosperities of tanshinone II(A)].
    Liu XQ; Meng QJ; Xu XL; Zhao J; Yang H; Yi H
    Zhongguo Zhong Yao Za Zhi; 2015 Dec; 40(24):4840-6. PubMed ID: 27245032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formulation and evaluation of liquisolid compacts of diclofenac sodium.
    Kulkarni AS; Gaja JB
    PDA J Pharm Sci Technol; 2010; 64(3):222-32. PubMed ID: 21502022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formulation of fenofibrate liquisolid tablets using central composite design.
    Patel T; Patel LD; Suhagia BN; Soni T; Patel T
    Curr Drug Deliv; 2014; 11(1):11-23. PubMed ID: 24712439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of dissolution rate of class II drugs (Hydrochlorothiazide); a comparative study of the two novel approaches; solid dispersion and liqui-solid techniques.
    Khan A; Iqbal Z; Shah Y; Ahmad L; Ismail ; Ullah Z; Ullah A
    Saudi Pharm J; 2015 Nov; 23(6):650-7. PubMed ID: 26702260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug release from liquisolid systems: speed it up, slow it down.
    Nokhodchi A; Hentzschel CM; Leopold CS
    Expert Opin Drug Deliv; 2011 Feb; 8(2):191-205. PubMed ID: 21222556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of Itraconazole Liquisolid Compact: Effect of Polyvinylpyrrolidone on the Dissolution Properties.
    Gong W; Wang Y; Sun L; Yang J; Shan L; Yang M; Gao C
    Curr Drug Deliv; 2016; 13(3):452-61. PubMed ID: 26882116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a New Aprepitant Liquisolid Formulation with the Aid of Artificial Neural Networks and Genetic Programming.
    Barmpalexis P; Grypioti A; Eleftheriadis GK; Fatouros DG
    AAPS PharmSciTech; 2018 Feb; 19(2):741-752. PubMed ID: 28980185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of flowable liquid retention potential of aluminometasilicate carrier for liquisolid systems preparation.
    Vraníková B; Gajdziok J; Vetchý D
    Pharm Dev Technol; 2015 Nov; 20(7):839-844. PubMed ID: 24927105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BCS class IV drugs: Highly notorious candidates for formulation development.
    Ghadi R; Dand N
    J Control Release; 2017 Feb; 248():71-95. PubMed ID: 28088572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissolution Enhancement of Rosuvastatin Calcium by Liquisolid Compact Technique.
    Kapure VJ; Pande VV; Deshmukh PK
    J Pharm (Cairo); 2013; 2013():315902. PubMed ID: 26555972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formulation factors affecting the release of ezetimibe from different liquisolid compacts.
    Khanfar M; Sheikh Salem M; Hawari R
    Pharm Dev Technol; 2013; 18(2):417-27. PubMed ID: 22530561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of solidified self-microemulsifying drug delivery systems containing l-tetrahydropalmatine: Design of experiment approach and bioavailability comparison.
    Tung NT; Tran CS; Pham TM; Nguyen HA; Nguyen TL; Chi SC; Nguyen DD; Bui TB
    Int J Pharm; 2018 Feb; 537(1-2):9-21. PubMed ID: 29246439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement of oral bioavailability of carvedilol by liquisolid compact: optimization and pharmacokinetic study.
    Jhaveri M; Nair AB; Shah J; Jacob S; Patel V; Mehta T
    Drug Deliv Transl Res; 2020 Aug; 10(4):975-985. PubMed ID: 32124413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of powder substrate on the dissolution properties of methyclothiazide liquisolid compacts.
    Spireas S; Wang T; Grover R
    Drug Dev Ind Pharm; 1999 Feb; 25(2):163-8. PubMed ID: 10065349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigating the use of liquisolid compacts technique to minimize the influence of pH variations on loratadine release.
    El-Hammadi M; Awad N
    AAPS PharmSciTech; 2012 Mar; 13(1):53-8. PubMed ID: 22101967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.